We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine
Published Online:https://doi.org/10.2217/fca-2022-0034

Cardiac masses are rare entities that present with a very varied spectrum of manifestations ranging from asymptomatic to severe hemodynamic compromise. They mainly correspond to benign neoplastic lesions; however, other pathologies may occur. The availability of high-definition imaging techniques has increased early detection. Nevertheless, these techniques do not allow the characterization and reliable differentiation of the nature of the mass. We describe a patient with no cardiovascular history with a chronic dyspnea, in whom the presence of a cardiac mass attached to the ventricle with slight deformation of the right cavities was identified by imaging studies. The patient underwent surgical resection, which confirmed the presence of lipoma by histopathology. This finding is the rarest of all benign cardiac tumors.

Plain language summary

Cardiac lipomas are rare benign tumors of the heart. They are usually asymptomatic, but when symptoms occur, they are usually nonspecific, so it is necessary to consult an internist, cardiologist or pulmonologist for proper study, identification and treatment. Multimodal images are very useful in these cases.

Papers of special note have been highlighted as: • of interest

References

  • 1. Abad C. Cardiac tumors. I. General considerations. Benign primary tumors. Rev. Esp. Cardiol. 51(1), 10–20 (1998).
  • 2. Maleszewski JJ, Anavekar NS, Moynihan TJ, Klarich KW. Pathology, imaging, and treatment of cardiac tumours. Nat. Rev. Cardiol. 14(9), 536–549 (2017).
  • 3. Gándara-Ricardo J, Muñoz-Ortiz E, Arévalo-Guerrero E, Mejía-Vélez A, Agamez-Gómez J, Senior JM. Cardiac masses: record of the experience in a high complexity center. Rev. Col. Cardiol. 26(1), 3–9 (2019).
  • 4. Pazos-López P, Pozo E, Siqueira ME et al. Value of CMR for the differential diagnosis of cardiac masses. JACC Cardiovasc. Imaging 7(9), 896–905 (2014).
  • 5. Cubides C, Salazar G, Muñoz A et al. Primary cardiac tumors. Rev. Col. Cardiol. 10, 472–485 (2003).
  • 6. Roberts WC. Primary and secondary neoplasm of the heart. Am. J. Cardiol. 80, 671–682 (1997).
  • 7. Graham TR, Chalmers JAC, Aidren C. A large epicardial lipoma: an insight into the surgical anatomy of the interatrial septum. Int. J. Cardiol. 25, 119–121 (1989).
  • 8. Shu S, Wang J, Zheng C. From pathogenesis to treatment, a systemic review of cardiac lipoma. J. Cardiothorac. Surg. 16, 1 (2021). • Recent review that analyzes the existing knowledge on cardiac lipomas.
  • 9. Shu S, Yuan H, Kong X, Wang J, Wang J, Zheng C. The value of multimodality imaging in diagnosis and treatment of cardiac lipoma. BMC Med. Imaging 21(1), 71 (2021). • Cardiac lipomas can be sensitively detected and accurately diagnosed with multiple noninvasive imaging tools.